GEODE CAPITAL MANAGEMENT, LLC - NEOS THERAPEUTICS INC ownership

NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 68 filers reported holding NEOS THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 1.57 and the average weighting 0.1%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of NEOS THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$212,000
+17.8%
340,7680.0%0.00%
Q3 2020$180,000
-22.7%
340,7680.0%0.00%
Q2 2020$233,000
-8.6%
340,7680.0%0.00%
Q1 2020$255,000
-76.6%
340,768
-52.9%
0.00%
Q4 2019$1,092,000
+104.1%
723,776
+100.0%
0.00%
Q3 2019$535,000
+16.3%
361,888
+1.5%
0.00%
Q2 2019$460,000
-62.7%
356,635
-24.5%
0.00%
Q1 2019$1,233,000
+1.7%
472,591
-35.7%
0.00%
Q4 2018$1,212,000
-3.8%
734,992
+182.8%
0.00%
Q3 2018$1,260,000
-19.0%
259,869
+4.4%
0.00%
Q2 2018$1,555,000
-10.5%
248,844
+18.8%
0.00%
-100.0%
Q1 2018$1,738,000
-17.9%
209,514
+0.9%
0.00%0.0%
Q4 2017$2,117,000
+31.7%
207,568
+18.1%
0.00%0.0%
Q3 2017$1,607,000
+73.4%
175,707
+38.3%
0.00%
Q2 2017$927,000
+38.6%
127,089
+36.7%
0.00%
Q1 2017$669,000
+48.7%
92,956
+20.7%
0.00%
Q4 2016$450,000
-8.0%
76,994
+3.5%
0.00%
Q3 2016$489,000
+8.7%
74,381
+53.3%
0.00%
Q2 2016$450,000
+7.9%
48,510
+25.4%
0.00%
Q1 2016$417,000
-20.6%
38,698
+5.4%
0.00%
Q4 2015$525,000
-31.7%
36,701
+0.2%
0.00%
Q3 2015$769,00036,6110.00%
Other shareholders
NEOS THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
DSC Advisors, L.P. 693,582$4,057,0002.30%
DAFNA Capital Management LLC 38,873$227,0000.20%
FALCON POINT CAPITAL, LLC 85,588$501,0000.07%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 229,166$1,341,0000.06%
Cormorant Asset Management, LP 50,613$296,0000.04%
PRELUDE CAPITAL MANAGEMENT, LLC 14,587$85,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 80,000$468,0000.01%
MILLENNIUM MANAGEMENT LLC 296,175$1,733,0000.00%
FRANKLIN RESOURCES INC 1,315,500$7,696,0000.00%
COLUMBUS CIRCLE INVESTORS 42,304$247,0000.00%
View complete list of NEOS THERAPEUTICS INC shareholders